Weight loss with orlistat

Reproduced with permission of the American Diabetes Association. From: Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27:155. Copyright © 2004; permission conveyed through Copyright Clearance Center, Inc.